Your browser doesn't support javascript.
loading
Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics.
Thakur, Abhimanyu; Parra, Diana Carolina; Motallebnejad, Pedram; Brocchi, Marcelo; Chen, Huanhuan Joyce.
Afiliación
  • Thakur A; Pritzker School of Molecular Engineering, The University of Chicago, United States.
  • Parra DC; Ben May Department for Cancer Research, The University of Chicago, United States.
  • Motallebnejad P; Tropical Disease Laboratory, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas (UNICAMP), São Paulo, Brazil.
  • Brocchi M; Pritzker School of Molecular Engineering, The University of Chicago, United States.
  • Chen HJ; Ben May Department for Cancer Research, The University of Chicago, United States.
Bioact Mater ; 10: 281-294, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34901546
ABSTRACT
Cancer is a deadly disease that is globally and consistently one of the leading causes of mortality every year. Despite the availability of chemotherapy, radiotherapy, immunotherapy, and surgery, a cure for cancer has not been attained. Recently, exosomes have gained significant attention due to the therapeutic potential of their various components including proteins, lipids, nucleic acids, miRNAs, and lncRNAs. Exosomes constitute a set of tiny extracellular vesicles with an approximate diameter of 30-100 nm. They are released from different cells and are present in biofluids including blood, cerebrospinal fluid (CSF), and urine. They perform crucial multifaceted functions in the malignant progression of cancer via autocrine, paracrine, and endocrine communications. The ability of exosomes to carry different cargoes including drug and molecular information to recipient cells make them a novel tool for cancer therapeutics. In this review, we discuss the major components of exosomes and their role in cancer progression. We also review important literature about the potential role of exosomes as vaccines and delivery carriers in the context of cancer therapeutics.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Bioact Mater Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Bioact Mater Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos